For instance, the pro-inflammatory cytokine IL-18 has been combined with chemotherapeutic agents for the treatment of the murine spontaneously tumorigenic MOSE ovarian cancer cell line ID8 [79]. The gene discussed is IL18; the disease is ovarian carcinoma.